MDMA cleared for Phase III Study in US re PTSD
The FDA cleared MDMA for a Phase III Study under the classification of a potential "Breakthrough Therapy". However, the study has not yet been funded. MAPS is currently raising money for the potential study.
Press Release: MAPS Press Release